Oragenics Inc. OGEN

$0.53 +0.53% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-13 View →
4 PRIMARY DOCUMENT 2026-07-07 View →
8-K 8-K 2026-07-06 View →
DEF 14A DEF 14A 2026-05-20 View →
8-K 8-K 2026-05-19 View →
10-Q 10-Q 2026-05-08 View →
8-K 8-K 2026-05-07 View →
8-K 8-K 2026-04-13 View →
8-K 8-K 2026-03-31 View →
10-K 10-K 2026-03-16 View →
8-K 8-K 2026-03-11 View →
S-3 S-3 2026-01-22 View →
8-K 8-K 2026-01-22 View →
8-K 8-K 2026-01-20 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
4 PRIMARY DOCUMENT 2025-12-15 View →
8-K 8-K 2025-12-15 View →
8-K 8-K 2025-11-12 View →
10-Q 10-Q 2025-11-07 View →
8-K 8-K 2025-10-21 View →
8-K 8-K 2025-09-02 View →
8-K 8-K 2025-08-11 View →
10-Q 10-Q 2025-08-08 View →
8-K 8-K 2025-07-02 View →
424B5 424B5 2025-07-02 View →
S-1 S-1 2025-06-23 View →
4 Insider transaction 2025-06-18 View →
4 Insider transaction 2025-06-16 View →
8-K 8-K 2025-05-28 View →
8-K 8-K 2025-05-20 View →
10-Q Quarterly report 2025-05-09 View →
8-K 8-K 2025-05-02 View →
8-K Current report (material event) 2025-04-09 View →
DEF 14A Proxy statement 2025-04-01 View →
8-K Current report (material event) 2025-03-27 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.53
Market Cap
$2.40 million
52-Week Range
$0.48 – $1.49
Average Volume
22K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.